Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted activation

Journal of Biological Chemistry

Volumn 278, Issue 34, 2003, Pages 32077-32082

  Samel, Dierk ^a   Müller, Dafne ^a   Gerspach, Jeannette ^a   Assohou Luty, Constance ^a   Sass, Gabriele ^b   Tiegs, Gisa ^b   Pfizenmaier, Klaus ^a   Wajant, Harald ^a,c  

^a UNIVERSITY OF STUTTGART   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ENERGY; ANTIGENS; CELL CULTURE; GROWTH KINETICS;

FUSION PROTEINS;

PROTEINS;

CELL PROTEIN; FAS LIGAND; FIBROBLAST ACTIVATION PROTEIN; HYBRID PROTEIN; MEMBRANE ANTIGEN; SC40 FASL PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; CELL LINE; FAS LIGAND PROTEIN; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; RECOMBINANT FUSION PROTEINS;

ANIMALIA;

EID: 0041856115     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M304866200     Document Type: Article

References (27)

1. Wajant, H. (2002) Science 296, 1635-1636
2. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993) Cell 75, 1169-1178
3. Tanaka, M, Suda, T., Takahashi, T., and Nagata, S. (1995) EMBO J. 14, 1129-1135
4. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., and Yagita, H. (1995) J. Exp. Med. 182, 1777-1783
5. Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., and Nagata, S. (1997) J Exp. Med. 186, 2045-2050
6. Tanaka, M., Itai, T., Adachi, M., and Nagata, S. (1998) Nat. Med. 4, 31-36
7. Schneider, P. Holler, N., Bodmer, J. L., Hahne, M., Frei, K., Fontana, A., and Tschopp, J. (1998) J. Exp. Med. 187, 1205-1213
8. Holler, N., Tardivel, A., Kovacsovics-Bankowski, M., Hertig, S., Gaide, O., Martinon, F., Tinel, A., Deperthes, D., Calderara, S., Schulthess, T., Engel, J., Schneider, P., and Tschopp, J. (2003) Mol. Cell. Biol. 23, 1428-1440
9. Timmer, T., de Vries, E. G., and De Jong, S. (2002) J. Pathol. 196, 125-134
10. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W. W., Kruzel, E. (1995) Mol. Cell. Biol. 15, 3032-3040
11. Muller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., and Galle, P. R. (1997) J. Clin. Invest. 99, 403-413
12. Muller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., and Krammer, P. H. (1998) J. Exp. Med. 188, 2033-2045
13. Ogasawara, J. Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A, Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993) Nature 364, 806-809
14. Galle, P. R., Hofmann, W, J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., and Runkel, L. (1995) J. Exp. Med. 182, 1223-1230
15. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., Krammer, P. H. (1989) Science 245, 301-305
16. Shimizu, M., Yoshimoto, T., Nagata, S., and Matsuzawa, A. (1996) Biochem. Biophys. Res. Commun. 228, 375-379
17. Wajant, H., Moosmayer, D., Wuest, T., Bartke, T., Gerlach, E., Schonherr, U., Peters, N., Scheurich, P., and Pfizenmaier, K. (2001) Oncogene 20, 4101-4106
18. Wuest, T., Gerlach, E., Banerjee, D., Gerspach, J., Moosmayer, D., and Pfizenmaier, K. (2002) Oncogene 21, 4257-4265
19. Muller, D. (2001) Herstellung und Anwendung rekombinanter Antikoerperderivate gegen das Fibroblast Activation Protein. Ph.D. thesis, University of Stuttgart, Stuttgart, Germany
20. Bergmeyer, H. U. (ed) (1984) Methods of enzymatic Analysis, Vol. 3, 3rd Ed., pp. 416-456, Wiley Verlag Chemie, Weinheim, Germany
21. Asher, A., Mule, J. J., Reichert, C. M., Shiloni, E., and Rosenberg, S. A. (1987) J. Immunol. 138, 963-974
22. Scanlan, M. J., Raj, B. K., Calvo, B., Garin-Chesa, P., Sanz-Moncasi, M. P., Healey, J. H., Old, L. J., and Rettig, W. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5657-5661
23. Seino, K., Kayagaki, N., Okumura, K., and Yagita, H. (1997) Nat. Med. 3, 165-170
24. Arai, H., Gordon, D., Nabel, E. G., and Nabel, G. J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 13862-13867
25. Shimizu, M., Fontana, A., Takeda, Y., Yagita, H., Yoshimoto, T., and Matsuzawa, A. (1999) J. Immunol. 162, 7350-7357
26. Behrens, C. K., Igney, F. H., Arnold, B., Moller, P., and Krammer, P. H. (2001) J. Immunol. 166, 3240-3247
27. Yonehara, S. (2002) Cytokine Growth Factor Rev. 13, 393-402